Im not to sure if people realise but the 5th of February is actually a little after 8 weeks for patients 18 and 19.
" Study Update, Quarterly Activities and Cash flow Report (Appendix 4C) for 2Q18 expected to be released on 29th January 2018 Investor call on 5th February 2018 "
So a lot of news in a very short time frame from here on in.
The new CE mark requirements placed on BSI and OSL place more emphasis on strong data and there being nothing out there equivilant, I think OSL now meet these requirements.
People have given up with the on going delays but I think they are really starting to get there now and hopefully this time next year we could see profit a third of todays share price.
OSL Price at posting:
15.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)